These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 33081580)

  • 1. Severe and prolonged hypocalcemia after a single dose of denosumab for metastatic breast cancer with diffuse bone involvement without prior calcium/vitamin D supplementations.
    Uhm SJ; Hall JA; Herrington JD
    J Oncol Pharm Pract; 2021 Jul; 27(5):1287-1290. PubMed ID: 33081580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged Hypocalcemia Following a Single Dose of Denosumab for Diffuse Bone Metastasis of Gastric Cancer after Total Gastrectomy.
    Iizumi S; Shimoi T; Nishikawa T; Kitano A; Sasada S; Shimomura A; Noguchi E; Yunokawa M; Yonemori K; Shimizu C; Fujiwara Y; Tamura K
    Intern Med; 2017 Nov; 56(21):2879-2882. PubMed ID: 28943574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Analysis of Denosumab-Induced Hypocalcemia in Bone Metastasis Treatment: Renal Dysfunction Is Not a Risk Factor for Its Incidence in a Strict Denosumab Administration Management System with Calcium/Vitamin D Supplementation.
    Saito Y; Takekuma Y; Komatsu Y; Sugawara M
    Biol Pharm Bull; 2021; 44(12):1819-1823. PubMed ID: 34853264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A RANKL Wrinkle: Denosumab-Induced Hypocalcemia.
    Laskowski LK; Goldfarb DS; Howland MA; Kavcsak K; Lugassy DM; Smith SW
    J Med Toxicol; 2016 Sep; 12(3):305-8. PubMed ID: 26987988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organic anxiety in a woman with breast cancer receiving denosumab.
    Lin KF; Chen KH; Huang WL
    Gen Hosp Psychiatry; 2015; 37(2):192.e7-8. PubMed ID: 25772947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Risk Prediction Model for Grade 2 or Higher Hypocalcemia in Patients With Bone Metastasis Treated With Denosumab Plus Cholecalciferol (Vitamin D
    Ikegami K; Hashiguchi M; Kizaki H; Yasumuro O; Funakoshi R; Hori S
    J Clin Pharmacol; 2022 Sep; 62(9):1151-1159. PubMed ID: 35383950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypocalcaemia in patients with metastatic bone disease treated with denosumab.
    Body JJ; Bone HG; de Boer RH; Stopeck A; Van Poznak C; Damião R; Fizazi K; Henry DH; Ibrahim T; Lipton A; Saad F; Shore N; Takano T; Shaywitz AJ; Wang H; Bracco OL; Braun A; Kostenuik PJ
    Eur J Cancer; 2015 Sep; 51(13):1812-21. PubMed ID: 26093811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High bone turnover status as a risk factor in symptomatic hypocalcemia following denosumab treatment in a male patient with osteoporosis.
    Ishikawa K; Nagai T; Tsuchiya K; Oshita Y; Kuroda T; Ito H; Tani S; Dodo Y; Toyone T; Inagaki K
    Clin Interv Aging; 2018; 13():1929-1934. PubMed ID: 30349211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe Hypocalcemia Associated With Denosumab in Metastatic Castration-Resistant Prostate Cancer: Risk Factors and Precautions for Treating Physicians.
    Autio KA; Farooki A; Glezerman IG; Chan A; Schneider CW; Barr HC; Seyboth BM; Kampel LJ; Danila DC; Rathkopf DE; Slovin SF; Scher HI; Morris MJ
    Clin Genitourin Cancer; 2015 Aug; 13(4):e305-e309. PubMed ID: 25559408
    [No Abstract]   [Full Text] [Related]  

  • 10. Impaired residual renal function predicts denosumab-induced serum calcium decrement as well as increment of bone mineral density in non-severe renal insufficiency.
    Miyaoka D; Imanishi Y; Ohara M; Hayashi N; Nagata Y; Yamada S; Mori K; Emoto M; Inaba M
    Osteoporos Int; 2019 Jan; 30(1):241-249. PubMed ID: 30187112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Denosumab-induced hypocalcemia post bariatric surgery-a severe and protracted course: a case report.
    Awang MH; Hatta SFWM; Mohamad AF; Ghani RA
    J Med Case Rep; 2023 Mar; 17(1):73. PubMed ID: 36859300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of denosumab versus zoledronic acid on calcium levels in cancer patients with bone metastasis: A retrospective cohort study.
    Nasser SM; Sahal A; Hamad A; Elazzazy S
    J Oncol Pharm Pract; 2019 Dec; 25(8):1846-1852. PubMed ID: 31694497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe hypocalcaemia following denosumab in a patient with cancer with vitamin D deficiency.
    Watthanasuntorn K; Abid H; Gnanajothy R
    BMJ Case Rep; 2018 Dec; 11(1):. PubMed ID: 30567243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of hypocalcemia in patients receiving denosumab for prevention of skeletal-related events in bone metastasis.
    Yerram P; Kansagra S; Abdelghany O
    J Oncol Pharm Pract; 2017 Apr; 23(3):179-184. PubMed ID: 26830549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypocalcemia post denosumab in patients with chronic kidney disease stage 4-5.
    Dave V; Chiang CY; Booth J; Mount PF
    Am J Nephrol; 2015; 41(2):129-37. PubMed ID: 25790847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of denosumab-induced hypocalcaemia in a patient with non-metastatic prostate cancer and renal impairment.
    Blackley S; Anderson K; Berg J
    J R Coll Physicians Edinb; 2015; 45(2):133-5. PubMed ID: 26181529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Life-threatening sustained hypocalcemia following Denosumab use in metastatic prostate cancer.
    Patell K; Ajay K; Al Armashi AR; Bawwab A; Ravakhah K
    J Oncol Pharm Pract; 2022 Apr; 28(3):698-702. PubMed ID: 34693819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of denosumab in dialysis patients on calcium and vitamin D supplements.
    Ullah A; Abdulnabi K; Khalil A; Alexander J; Pai P; Mishra V
    Saudi J Kidney Dis Transpl; 2017; 28(1):158-161. PubMed ID: 28098118
    [No Abstract]   [Full Text] [Related]  

  • 19. Use and safety of denosumab in cancer patients.
    Manzaneque A; Chaguaceda C; Mensa M; Bastida C; Creus-Baró N
    Int J Clin Pharm; 2017 Jun; 39(3):522-526. PubMed ID: 28382583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Denosumab-induced severe hypocalcaemia in a patient with vitamin D deficiency.
    Daga N; Joseph F
    BMJ Case Rep; 2020 Aug; 13(8):. PubMed ID: 32847872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.